THE FOUR FIELDS OF MICROBIOLOGY AND INFECTIOUS DISEASES FOR R&D APPLICATIONS
WE AIM TO PROVIDE YOU WITH INNOVATIVE SCIENTIFIC, TECHNOLOGICAL, AND FINANCIAL SOLUTIONS TO ACCELERATE THE DEVELOPMENT OF YOUR PRODUCT.
Our purpose is to design and implement tailored technological solutions that open new areas of opportunity or overcome technological barriers that you have identified during the development process.
We aim to provide unmatched scientific and technological expertise throughout the discovery and development pathways in microbiology and infectious diseases.
We are at your side throughout your development program, from its co-design to the supply of the expected, robust deliverables that meet your industrial needs.
Our scientific and technical experts design the most appropriate development plan and identify the technologies to be implemented in discussion with you and your own experts. This development program is executed by our multidisciplinary teams, using our technical platforms. Whenever required, we can involve our extensive network of partners to further facilitate your program.
In addition, we make sure that you are able to manage risk in three areas:
- scientifically, using a holistic approach, from conception to data delivery, allowing you to make timely, informed decisions;
- technologically, by using the most appropriate and robust technologies;
- financially, through cost and return sharing, particularly when the aim is to overcome technological obstacles or improve on the current state-of-the-art.
OUR END-TO-END R&D PROGRAMS IN THE FIELDS OF ANTIMICROBIALS, VACCINES, THE MICROBIOME, & DIAGNOSTICS
Our solutions are aimed at deciphering the mechanisms underlying infections; understanding host-pathogen interactions; identifying novel targets; characterizing, identifying, and validating relevant biomarkers and signatures for use in diagnostics or therapeutics; selecting optimal therapeutic or diagnostic solutions; and contributing to the development of these solutions until their clinical relevance is identified.
We can support your ambitions in the following four areas:
Antimicrobials: Overcome hard-to-treat pathogens and multi-drug resistant bacteria
Vaccines: Enabling rational vaccine design through proven biological approaches
Microbiome: Exploiting the microbiota as a novel avenue to understand and validate prophylactic and therapeutic approaches
Diagnostics: Developing and successfully implementing diagnostic assays and devices that are tailored to patient needs